Moneycontrol PRO
you are here: HomeNewsUs market
us market
Jump to
339 Results Found
  • T-Hub inks MoU with Redberri Earth Foundation under its T-Bridge initiative Sep 30, 2021 07:14 PM IST

    T-Hub inks MoU with Redberri Earth Foundation under its T-Bridge initiative

    Under the partnership, T-Hub and Redberri will provide Indian and Chicago startups with business opportunities, market understanding and access to clients in Chicago and India, respectively.

  • Dr Reddy's launches generic stomach ulcer drug in US market Aug 31, 2021 03:02 PM IST

    Dr Reddy's launches generic stomach ulcer drug in US market

    The company has launched Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules USP, 5 mg/2.5 mg in the US market, Dr Reddy's Laboratories said in a regulatory filing.

  • Google brings Samsung 5G modem tech to US market with new Pixel phone Aug 26, 2021 07:45 AM IST

    Google brings Samsung 5G modem tech to US market with new Pixel phone

    Earlier this month, Google disclosed that it has designed its own processor chip to power its new Pixel 6 and Pixel 6 Pro high-end phones, ending its complete reliance on Qualcomm, which will still supply chips for the lower-priced Pixel 5A.

  • Here's what is driving the market higher and what can pull it down Aug 05, 2021 10:32 AM IST

    Here's what is driving the market higher and what can pull it down

    While India’s fundamentals are looking up, the big question to be asked is: what is happening to liquidity? 

  • Alkem Laboratories launches Ibuprofen, Famotidine tablets in US market Aug 04, 2021 10:49 AM IST

    Alkem Laboratories launches Ibuprofen, Famotidine tablets in US market

    Ibuprofen and Famotidine Tablets is AB-rated generic therapeutic equivalent version of Horizon Medicines LLC's Duexis Tablets, 800 mg/26.6 mg.

  • China's tech crackdown unlikely to cause much damage Jul 29, 2021 09:39 AM IST

    China's tech crackdown unlikely to cause much damage

    While the immediate damage may be curtailed to some extent, what is the guarantee that China will not change the rules of the game again? 

  • Indian customers can now invest in five new global markets: ICICI Direct May 24, 2021 05:23 PM IST

    Indian customers can now invest in five new global markets: ICICI Direct

    ICICI Direct has expanded its global investment facility to the United Kingdom, Japan, Hong Kong Germany and Singapore.

  • Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market Mar 14, 2021 11:29 AM IST

    Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market

    As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, which is used to treat chronic dry eye.

  • S&P 500, Nasdaq scale record highs as Joe Biden takes office, Netflix shares surge Jan 21, 2021 12:10 AM IST

    S&P 500, Nasdaq scale record highs as Joe Biden takes office, Netflix shares surge

    Shares of the world's largest streaming service surged 14% to add more than $30 billion to its market capitalization, helping boost the broader tech-heavy Nasdaq 100 index .

  • US stocks stumble on fears of looming recession Aug 15, 2019 02:25 AM IST

    US stocks stumble on fears of looming recession

    All three major U.S. indexes were sharply lower as short- and long-dated Treasury yields inverted for the first time in 12 years, a potential signal of imminent recession.

  • Indian cos may spend big on capex to step up regulatory compliance, says Ind-Ra Jul 10, 2019 08:10 PM IST

    Indian cos may spend big on capex to step up regulatory compliance, says Ind-Ra

    The credit rating firm said it expects near doubling of research and development investments as Indian companies launch complex generics, specialty and biosimilar drugs

  • Opinion | Despite near-term uncertainty, earnings growth has reached an inflection point Apr 09, 2019 08:21 AM IST

    Opinion | Despite near-term uncertainty, earnings growth has reached an inflection point

    Investors would do well to look beyond the elections.

  • Dr Reddy's continues to recall Levetiracetam Injection from US market Feb 06, 2019 10:27 AM IST

    Dr Reddy's continues to recall Levetiracetam Injection from US market

    According to a letter written to the US Food and Drug Administration on Februray 4, the drug maker said the recall, which began in October 2018, was originally initiated due to a product complaint received for mislabelling.

  • Sun Pharma recalls about 14k cartons of anaesthesia injection from US market Jan 09, 2019 03:47 PM IST

    Sun Pharma recalls about 14k cartons of anaesthesia injection from US market

    "Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries, Ltd. is voluntarily recalling three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized powder), and one lot of Vecuronium Bromide for Injection, 20 mg (lyophilized powder) to the hospital level.

  • Dr Reddy's launches oral suspension drug in the US market Dec 27, 2018 12:41 PM IST

    Dr Reddy's launches oral suspension drug in the US market

    The newly launched product is in the strengths of 0.8 g and 2.4 g packets, and is a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for oral suspension, approved by the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a BSE filing.

  • Dr Reddy's launches anti-coagulant drug in US market Dec 24, 2018 11:41 AM IST

    Dr Reddy's launches anti-coagulant drug in US market

    The product is a therapeutic equivalent to generic version of Aggrenox (aspirin and extended-release dipyridamole) capsules, the company said in a BSE filing.

  • Dr Reddy's launches blood pressure drug in US Nov 28, 2018 11:19 AM IST

    Dr Reddy's launches blood pressure drug in US

    Dr Reddy's Laboratories Ltd launched Chlorthalidone tablets USP in the strengths of 25 mg and 50 mg, a therapeutic equivalent generic version of Hygroton tablets, Dr Reddy's Laboratories said in a BSE filing.

  • Dr Reddy's Labs announces generic version of Straterra in US market Oct 31, 2018 01:52 PM IST

    Dr Reddy's Labs announces generic version of Straterra in US market

    The Hyderabad-based company has received the approval from the US Food and Drug Administration (USFDA) to market its product which is a generic equivalent of Eli Lilly and Company's Straterra, Dr Reddy's Laboratories said in a statement.

  • Lupin gets USFDA nod for generic skin treatment ointment Oct 22, 2018 04:36 PM IST

    Lupin gets USFDA nod for generic skin treatment ointment

    The company has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Mylan Pharmaceuticals Inc's Triamcinolone Acetonide Ointment, Lupin said in a statement.

  • Chinese exporters scramble to cope with Trump tariff hike Apr 16, 2018 02:35 PM IST

    Chinese exporters scramble to cope with Trump tariff hike

    They are weighing plans to rush shipments to American customers ahead of the increase, raise prices or find other markets. Some are looking at shipping goods through other countries to hide their Chinese origin.

  • General Motors sees flat 2018 earnings, with pickups picking up in 2019 Jan 17, 2018 08:10 AM IST

    General Motors sees flat 2018 earnings, with pickups picking up in 2019

    GM forecast 2017 earnings per share at the high end of its previously forecast range of $6 to $6.50. The company expects earnings for 2018 to be roughly the same as in 2017. Analysts have predicted full-year 2017 earnings per share of $6.30, and $5.98 a share in 2018.

  • Keep close eye on US mkt; 10,100 not good support for Nifty, sell on rallies: Pros Dec 04, 2017 04:15 PM IST

    Keep close eye on US mkt; 10,100 not good support for Nifty, sell on rallies: Pros

    Mitessh Thakkar of mistesshthakkar.com said selling on rally would help and momentum would come in once we break below 10,100, then we could see severe declines.

  • What changed for the market while you were sleeping? 10 things you should know Sep 01, 2017 07:50 AM IST

    What changed for the market while you were sleeping? 10 things you should know

    A look at top cues from the domestic and international markets that could have a bearing on D-Street today.

  • Lupin initiates recall of tablet Mibelas 24 Fe from the US market Aug 24, 2017 02:01 PM IST

    Lupin initiates recall of tablet Mibelas 24 Fe from the US market

    According to a notification issued by the US Food and Drug Administration (USFDA), as many as 24,652 tablets are being recalled under 'class-I' classification.

  • Dow Jones chalks up eighth record close in a row after strong jobs data Aug 05, 2017 08:25 AM IST

    Dow Jones chalks up eighth record close in a row after strong jobs data

    The Dow Jones Industrial Average rose 0.3 percent to end at 22,092.81, an all-time high. The S&P 500 gained 0.19 percent to 2,476.83 and the Nasdaq Composite added 0.18 percent to 6,351.56.

Sections
ISO 27001 - BSI Assurance Mark